Leap Therapeutics
LPTX
LPTX
72 hedge funds and large institutions have $32.7M invested in Leap Therapeutics in 2022 Q3 according to their latest regulatory filings, with 12 funds opening new positions, 18 increasing their positions, 15 reducing their positions, and 10 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
72
Holders Change
+2
Holders Change %
+2.86%
% of All Funds
1.25%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
12
Increased
18
Reduced
15
Closed
10
Calls
$255K
Puts
$27K
Net Calls
+$228K
Net Calls Change
-$144K
Top Buyers
| 1 |
6CM
1
683 Capital Management
New York
|
$1.99M |
| 2 |
TLP
2
Tri Locum Partners
New York
|
$626K |
| 3 |
DMKJ
3
David M. Knott Jr
|
$792K |
| 4 |
4
Jane Street
New York
|
$115K |
| 5 |
KCFA
5
Key Client Fiduciary Advisors
Fairfield,
New Jersey
|
$986K |
Top Sellers
| 1 |
1
Millennium Management
New York
|
$416K |
| 2 |
DAM
2
DLD Asset Management
New York
|
$0 |
| 3 |
PA
3
Perceptive Advisors
New York
|
$6.58M |
| 4 |
4
Two Sigma Advisers
New York
|
$364K |
| 5 |
5
Renaissance Technologies
New York
|
$344K |
